On January 22, 2026, Decentralized Autonomous Organizations (DAOs) allocated $7 million to quantum biology, signaling a paradigm shift in scientific funding.
Through DeSci (Decentralized Science), blockchain smart contracts allow token holders to govern research priorities. Funds are held in multisig wallets and disbursed upon consensus, ensuring full on-chain transparency.
This capital targets quantum phenomena in biology, including quantum tunneling in enzyme catalysis and coherent exciton transfer in photosynthesis.
Grants also probe spin-dependent radical pairs in magnetoreception and potential quantum effects within neural microtubules and ion channels.
Bypassing traditional peer-review delays, the DAO model prioritizes high-risk, interdisciplinary experiments like spectroscopic assays to measure in vivo coherence.